Aclaris Therapeutics, Inc. (ACRS) Institutional Ownership & Insider Trading
149 institutions reported holding Aclaris Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 1 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ACRSAclaris Therapeutics, Inc.Follow ACRS — free
—
Price chart with a free account
- Market cap
- 552.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters149 institutions held 82.3% of the shares. Across filers that reported both quarters, shares held changed +10.1%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 149 | 121 | +10.1% | 65 | 27 | 29 | 10 |
| Mar 26 | 136 | 111 | +36.9% | 40 | 28 | 36 | 14 |
| Dec 25 | 121 | 84 | -5.2% | 31 | 18 | 37 | 6 |
| Sep 25 | 103 | 86 | -5.9% | 24 | 15 | 39 | 7 |
| Jun 25 | 96 | 92 | -0.9% | 30 | 23 | 25 | 36 |
| Mar 25 | 107 | 92 | +6.1% | 38 | 23 | 24 | 11 |
| Dec 24 | 97 | 87 | +75.6% | 25 | 26 | 24 | 14 |
| Sep 24 | 80 | 51 | -3.2% | 20 | 7 | 27 | 23 |
Aclaris Therapeutics, Inc. — questions
- Who owns Aclaris Therapeutics, Inc. stock?
- 149 institutions reported Aclaris Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: RA CAPITAL MANAGEMENT, L.P. (8.6%), BML Capital Management, LLC (8.1%), BlackRock, Inc. (6.8%).
- Are Aclaris Therapeutics, Inc. insiders buying or selling?
- 1 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Aclaris Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.